InvestorsHub Logo
Followers 9
Posts 627
Boards Moderated 0
Alias Born 06/22/2007

Re: None

Monday, 11/19/2018 11:05:02 AM

Monday, November 19, 2018 11:05:02 AM

Post# of 425931
By next summer

Almost everyone on Statin's will be on this drug. Thats about 30 million patients of which they earn 2400 dollars in revenue per patient per year.

(2400*30 million)/(370 million) = 194.6$ revenue per share

194.6*(profit margin I am assuming .6)=116.756 profit per share (minus some fixed cost so lets say 100 dollars a share)

So selling this company for 45 dollars is unwise and its going a lot higher then most of you think.

If you can tell me where I'm wrong I'd like to hear it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News